Sfoglia per Rivista CANCER CHEMOTHERAPY AND PHARMACOLOGY
A randomized comparison of the acceleraded folinic acid and 5-fluorouracil versus the conventional 5-fluorouracil schedule in advanced colorectal cancer. Supportive care and quality of life.
1994-01-01 Petrioli, R; Lorenzi, M; Mancini, S; Aquino, A; De Sando, D; Marsili, S; Frediani, Bruno; Palazzuoli, V; Marzocca, G; Botta, Giuseppe; Testi, W; Setacci, Carlo; Salvestrini, F; De Martino, A.
Advanced breast cancer treatment with folinic acid, 5-fluorouracil, and mytomicin C
1993-01-01 Francini, G.; Petrioli, R.; Aquino, A.; Gonnelli, S.
Dual targeting of tumour cells and host endothelial cells by novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines
2010-01-01 Nathwani, S. M.; Butler, S.; Meegan, M. J.; Campiani, G.; Lawler, M.; Williams, D. C.; Zisterer, D. M.
First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers
2022-01-01 Felip, E.; Moreno, V.; Morgensztern, D.; Curigliano, G.; Rutkowski, P.; Trigo, J. M.; Calvo, A.; Kowalski, D.; Cortinovis, D.; Plummer, R.; Maio, M.; Ascierto, P. A.; Vladimirov, V. I.; Cervantes, A.; Zudaire, E.; Hazra, A.; T'Jollyn, H.; Bandyopadhyay, N.; Greger, J. G.; Attiyeh, E.; Xie, H.; Calvo, E.
Folinic acid, 5-fluorouracil and mitomycin C in metastatic breast cancer patients previously treated with at least two chemotherapy regimens
2002-01-01 Francini, G.; Petrioli, R.; Messinese, S.; Pozzessere, D.; Marsili, S.; Correale, P.; Sabatino, M.; Fiaschi, A. I.
Gastric cancer with para-aortic lymph node metastases: do not miss a chance of cure!
2014-01-01 Marrelli, Daniele; Mazzei, MARIA ANTONIETTA; Roviello, Franco
Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer
2005-01-01 Correale, Pierpaolo; Fulfaro, Fabio; Marsili, Stefania; Cicero, Giuseppe; Bajardi, Eugenia; Intrivici, Chiara; Vuolo, Giuseppe; Carli, Antonio Ferdinando; Caraglia, Michele; Prete, Salvatore Del; Greco, Ettore; Gebbia, Nicola; Francini, Guido
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study
2015-01-01 Petrioli, Roberto; Roviello, Giandomenico; Fiaschi, ANNA IDA; Laera, Letizia; Marrelli, Daniele; Roviello, Franco; Francini, Edoardo
Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with colon and gastric cancer: a randomized study of two different schedules of oxaliplatin.
2008-01-01 Petrioli, R; Pascucci, A; Francini, E; Marsili, S; Sciandivasci, A; Tassi, R; Civitelli, Serenella; Tanzini, G; Lorenzi, Marco; Francini, Guido
Novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines, induce apoptosis in multi-drug-resistant cancer cells
2010-01-01 Nathwani, S. M.; Butler, S.; Fayne, D.; Mcgovern, N. N.; Sarkadi, B.; Meegan, M. J.; Lloyd, D. G.; Campiani, G.; Lawler, M.; Williams, D. C.; Zisterer, D. M.
Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate
2015-01-01 Petrioli, Roberto; Francini, E; Ponchietti, Roberto; Roviello, Giandomenico; Laera, Letizia; Fiaschi, ANNA IDA
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience
2015-01-01 Petrioli, Roberto; Francini, Edoardo; Roviello, Franco; Marrelli, Daniele; Fiaschi, ANNA IDA; Laera, Letizia; Rossi, Giulia; Bianco, V; Brozzetti, S; Roviello, Giandomenico
Vascular activity of two silicon compounds, ALIS 409 and ALIS 421, novel multidrug-resistance reverting agents in cancer cells
2008-01-01 Fusi, Fabio; Ferrara, A.; Zalatnai, A.; Molnar, J.; Sgaragli, Gian Pietro; Saponara, Simona
Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
---|---|---|---|---|
A randomized comparison of the acceleraded folinic acid and 5-fluorouracil versus the conventional 5-fluorouracil schedule in advanced colorectal cancer. Supportive care and quality of life. | 1-gen-1994 | Petrioli, R; Lorenzi, M; Mancini, S; Aquino, A; De Sando, D; Marsili, S; Frediani, Bruno; Palazzuoli, V; Marzocca, G; Botta, Giuseppe; Testi, W; Setacci, Carlo; Salvestrini, F; De Martino, A. | - | |
Advanced breast cancer treatment with folinic acid, 5-fluorouracil, and mytomicin C | 1-gen-1993 | Francini, G.; Petrioli, R.; Aquino, A.; Gonnelli, S. | - | |
Dual targeting of tumour cells and host endothelial cells by novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines | 1-gen-2010 | Nathwani, S. M.; Butler, S.; Meegan, M. J.; Campiani, G.; Lawler, M.; Williams, D. C.; Zisterer, D. M. | - | |
First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers | 1-gen-2022 | Felip, E.; Moreno, V.; Morgensztern, D.; Curigliano, G.; Rutkowski, P.; Trigo, J. M.; Calvo, A.; Kowalski, D.; Cortinovis, D.; Plummer, R.; Maio, M.; Ascierto, P. A.; Vladimirov, V. I.; Cervantes, A.; Zudaire, E.; Hazra, A.; T'Jollyn, H.; Bandyopadhyay, N.; Greger, J. G.; Attiyeh, E.; Xie, H.; Calvo, E. | - | |
Folinic acid, 5-fluorouracil and mitomycin C in metastatic breast cancer patients previously treated with at least two chemotherapy regimens | 1-gen-2002 | Francini, G.; Petrioli, R.; Messinese, S.; Pozzessere, D.; Marsili, S.; Correale, P.; Sabatino, M.; Fiaschi, A. I. | - | |
Gastric cancer with para-aortic lymph node metastases: do not miss a chance of cure! | 1-gen-2014 | Marrelli, Daniele; Mazzei, MARIA ANTONIETTA; Roviello, Franco | - | |
Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer | 1-gen-2005 | Correale, Pierpaolo; Fulfaro, Fabio; Marsili, Stefania; Cicero, Giuseppe; Bajardi, Eugenia; Intrivici, Chiara; Vuolo, Giuseppe; Carli, Antonio Ferdinando; Caraglia, Michele; Prete, Salvatore Del; Greco, Ettore; Gebbia, Nicola; Francini, Guido | - | |
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study | 1-gen-2015 | Petrioli, Roberto; Roviello, Giandomenico; Fiaschi, ANNA IDA; Laera, Letizia; Marrelli, Daniele; Roviello, Franco; Francini, Edoardo | - | |
Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with colon and gastric cancer: a randomized study of two different schedules of oxaliplatin. | 1-gen-2008 | Petrioli, R; Pascucci, A; Francini, E; Marsili, S; Sciandivasci, A; Tassi, R; Civitelli, Serenella; Tanzini, G; Lorenzi, Marco; Francini, Guido | - | |
Novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines, induce apoptosis in multi-drug-resistant cancer cells | 1-gen-2010 | Nathwani, S. M.; Butler, S.; Fayne, D.; Mcgovern, N. N.; Sarkadi, B.; Meegan, M. J.; Lloyd, D. G.; Campiani, G.; Lawler, M.; Williams, D. C.; Zisterer, D. M. | - | |
Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate | 1-gen-2015 | Petrioli, Roberto; Francini, E; Ponchietti, Roberto; Roviello, Giandomenico; Laera, Letizia; Fiaschi, ANNA IDA | - | |
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience | 1-gen-2015 | Petrioli, Roberto; Francini, Edoardo; Roviello, Franco; Marrelli, Daniele; Fiaschi, ANNA IDA; Laera, Letizia; Rossi, Giulia; Bianco, V; Brozzetti, S; Roviello, Giandomenico | - | |
Vascular activity of two silicon compounds, ALIS 409 and ALIS 421, novel multidrug-resistance reverting agents in cancer cells | 1-gen-2008 | Fusi, Fabio; Ferrara, A.; Zalatnai, A.; Molnar, J.; Sgaragli, Gian Pietro; Saponara, Simona | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile